ProShares Ultra NASDAQ Biotechnology
32 hedge funds and large institutions have $26.1M invested in ProShares Ultra NASDAQ Biotechnology in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.
Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
11
Reduced
7
Closed
4
Calls
$16.6M
Puts
$18.3M
Net Calls
-$1.73M
Net Calls Change
+$3.63M